Rhythm Pharmaceuticals, Inc (RYTM) insider trading
Every open-market stock purchase and sale by Rhythm Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Jennifer Kayden Lee (VP) and 5 others sold $28.8M in the last 90 days.
- Last insider buy: David P Meeker (CEO), $202K, 5 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $41.7M (18 sales). Last close $104.89 on Sep 3, 2026.
Recent RYTM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 14, 2026 | David P Meeker (CEO) | Sold | $3.1M |
| Sep 14, 2026 | David P Meeker (CEO) | Sold | $900K |
| Sep 14, 2026 | David P Meeker (CEO) | Sold | $655K |
| Sep 14, 2026 | David P Meeker (CEO) | Sold | $242K |
| Sep 14, 2026 | David P Meeker (CEO) | Sold | $190K |
| Sep 14, 2026 | David P Meeker (CEO) | Bought (not open market) | — |
| Aug 31, 2026 | Hunter C Smith (CFO) | Sold | $3M |
| Aug 31, 2026 | Hunter C Smith (CFO) | Sold | $2.4M |
| Aug 31, 2026 | Hunter C Smith (CFO) | Sold | $1.2M |
| Aug 31, 2026 | Hunter C Smith (CFO) | Bought (not open market) | — |
| Aug 17, 2026 | Manher Joshi (C-suite exec) | Bought (not open market) | — |
| Aug 17, 2026 | Manher Joshi (C-suite exec) | Bought (not open market) | — |
| Aug 13, 2026 | Jennifer Kayden Lee (VP) | Sold | $8.9M |
| Aug 13, 2026 | Joseph Shulman (CTO) | Sold | $608K |
| Aug 13, 2026 | Alastair Garfield (C-suite exec) | Sold | $402K |
| Aug 13, 2026 | Alastair Garfield (C-suite exec) | Sold | $233K |
| Aug 13, 2026 | Alastair Garfield (C-suite exec) | Sold | $182K |
| Aug 13, 2026 | Alastair Garfield (C-suite exec) | Sold | $95.3K |
| Aug 13, 2026 | Joseph Shulman (CTO) | Bought (not open market) | — |
| Aug 13, 2026 | Jennifer Kayden Lee (VP) | Bought (not open market) | — |
| Aug 13, 2026 | Jennifer Kayden Lee (VP) | Bought (not open market) | — |
| Aug 12, 2026 | Yann Mazabraud (VP) | Sold | $2.1M |
| Aug 12, 2026 | Yann Mazabraud (VP) | Sold | $2M |
| Aug 12, 2026 | Yann Mazabraud (VP) | Sold | $1.7M |
| Aug 12, 2026 | Yann Mazabraud (VP) | Sold | $413K |
Who's trading RYTM
- David P Meeker, CEO: sold $5.1M (5 sales), last Sep 14, 2026
- Hunter C Smith, CFO: sold $8.8M (25 sales), last Aug 31, 2026
- Manher Joshi, C-suite exec: other filings, last Aug 17, 2026
- Joseph Shulman, CTO: sold $3.7M (6 sales), last Aug 13, 2026
- Jennifer Kayden Lee, VP: sold $8.9M (1 sale), last Aug 13, 2026
- Alastair Garfield, C-suite exec: sold $913K (4 sales), last Aug 13, 2026
- Yann Mazabraud, VP: sold $6.6M (6 sales), last Aug 12, 2026
- Lynn A. Tetrault, Director: sold $3.7M (1 sale), last Jun 24, 2026
- Jennifer L Good, Director: other filings, last Jun 24, 2026
- Christophe Jean, Director: other filings, last Jun 24, 2026
- David W J McGirr, Director: other filings, last Jun 24, 2026
- Stuart A Arbuckle, Director: other filings, last Jun 24, 2026
- Christopher Paul German, C-suite exec: sold $931K (2 sales), last May 15, 2026
- Kimberly J Popovits, Director: other filings, last Apr 1, 2026
- Edward T Mathers, Insider: other filings, last Mar 12, 2026
Get free alerts when an insider at Rhythm Pharmaceuticals, Inc files a new trade →